等待开盘 11-17 09:30:00 美东时间
+2.610
+1.01%
原标题:这个低迷了四年的赛道,正在被大手笔扫货 让优利特集团常务副总裁黄杰没有想到的是,IVD行业的本轮出清持续时间如此之长,而且还没有看到缓和的迹象。 国内...
11-16 08:10
SECAUCUS, N.J., Nov. 10, 2026 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), a leading provider of diagnostic information services, today announced that its Board of Directors declared a qua...
11-11 05:06
华盛资讯10月24日讯,奎斯特诊疗公布2026财年Q3业绩,公司Q3营收30.97亿美元,同比增长10.0%,归母净利润3.12亿美元,同比增长27.3%。
10-24 04:31
华盛资讯10月22日讯,奎斯特诊疗公布2026财年Q3业绩,公司Q3营收30.97亿美元,同比增长10.0%,归母净利润3.12亿美元,同比增长27.3%。
10-22 19:02
On October 21, 2026, Quest Diagnostics Incorporated (the "Company") learned of unauthorized access to its Quanum LSM system, which certain clients use to place test orders, receive and look up results. The Company promptly initiated its cybersecurity incident response procedures to contain the activ...
10-22 18:58
Quest Diagnostics (NYSE:DGX) raises FY2026 GAAP EPS guidance from $9.97-$10.17 to $10.21-$10.31 vs $10.15 analyst estimate..
10-22 18:49
奎斯特诊断(Quest Diagnostics,NYSE: DGX)公布2026财年第三季度净营收为30.97亿美元,同比增长10.0%;同时GAAP稀释后每股收益增长28.7%至2.78美元,调整后每股收益增长15.4%至3.00美元。有机检测申请量增长14.4%,抵消了每份申请收入下降4.2%的影响,调整后营业利润率提升40个基点至16.7%。本季度经营活动现金流达6.11亿美元。该公司上调了全年营收、每股收益及经营活动现金流指引,同时保持约5.5亿美元的资本支出展望不变。
10-22 10:53
今日重点评级关注:DA Davidson:维持美光科技"买入"评级,目标价从2100美元升至3000美元;Leerink Partners:维持OmniAb"跑赢大市"评级,目标价从10美元升至12美元
10-08 12:30
Barclays analyst Luke Sergott maintains Quest Diagnostics (NYSE:DGX) with a Overweight and raises the price target from $250 to $260.
10-07 23:17